Congressional and Administration Leaders Address Clinical Laboratory Community on Legislative and Regulatory Initiatives Impacting Diagnostics at ACLA’s 21st Annual Conference

March 03, 2016 Categories: ACLA News, All News, Featured News, ACLA Press Releases

(Washington, D.C.) –The diagnostic community and the critical role it plays in patient diagnoses and treatment plans was the focal point of various presentations today as congressional, regulatory and administration leaders addressed meeting attendees at the American Clinical Laboratory Association’s (ACLA) 21st Annual Conference in Washington, DC.

“Clinical laboratories are a critical part of the scientific innovation that has brought us to the forefront of personalized medicine and can be credited with helping to transform the practice of medicine and improve patient outcomes,” said Alan Mertz, President of the ACLA. “The clinical laboratory community is an invaluable partner in the mission to promote and advance America’s health.”

House Ways and Means Chairman Kevin Brady (R-TX) provided a congressional overview of health care policies impacting diagnostics, while Jeffrey E. Shuren, M.D., Director for Devices and Radiological Health for the Food and Drug Administration (FDA) addressed conference attendees on the agency’s views on the oversight of laboratory developed tests (LDTs). Marc Hartstein, Director of the Hospital and Ambulatory Policy Group for the Centers for Medicare and Medicaid Services (CMS), led a panel on Medicare reimbursement for clinical labs. On the heels of Super Tuesday election results, veteran CBS reporter and former longtime host of Face the Nation, Bob Schieffer, delivered the keynote address on the nation’s political landscape in this presidential election year, including the issues and candidates most influential in driving voters’ opinions.

“Now more than ever, the value of clinical diagnostics must be recognized as congressional and federal agency decision-makers develop regulatory and reimbursement changes that impact clinical laboratory testing services,” said Mertz. “ACLA’s annual conference is a powerful forum for the exchange of ideas and robust debate on issues that ultimately impact patient lives.”

To access the full agenda for ACLA’s annual conference held March 3 at the Grand Hyatt Hotel, click here.


# # #
The ACLA is a not-for-profit association representing the nation’s leading national, regional and esoteric clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies.

Print page / Save as PDF